Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Payables (2021 - 2026)

Aveanna Healthcare Holdings' Payables history spans 6 years, with the latest figure at $38.1 million for Q1 2026.

  • For Q1 2026, Payables fell 8.27% year-over-year to $38.1 million; the TTM value through Jan 2026 reached $38.1 million, down 8.27%, while the annual FY2026 figure was $38.1 million, 8.27% down from the prior year.
  • Payables reached $38.1 million in Q1 2026 per AVAH's latest filing, up from $27.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $57.7 million in Q1 2022 to a low of $27.1 million in Q3 2025.
  • Average Payables over 5 years is $42.8 million, with a median of $41.9 million recorded in 2024.
  • Peak YoY movement for Payables: soared 31.08% in 2022, then crashed 35.39% in 2025.
  • A 5-year view of Payables shows it stood at $50.8 million in 2022, then tumbled by 32.9% to $34.1 million in 2023, then increased by 22.01% to $41.6 million in 2024, then crashed by 34.86% to $27.1 million in 2025, then surged by 40.83% to $38.1 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's Payables are $38.1 million (Q1 2026), $27.1 million (Q3 2025), and $46.6 million (Q2 2025).